Intuitive Investments Group plc
Proposed Investment in Microsaic Systems plc
Intuitive Investments Group plc (AIM: IIG) ("IIG"), a closed-end investment company focussed on the life sciences sector, announces an investment of £250,000 to acquire 250 million ordinary shares of Microsaic Systems plc (AIM: MSYS) ("Microsaic") at a price of 0.1 pence per share (the "Investment"). The Investment is part of Microsaic's fundraising as announced by Microsaic on 19 January 2021 (the "Fundraising"). The Investment is conditional upon, amongst other things, each of the resolutions being passed at Microsaic's forthcoming general meeting on 4 February 2021.
Microsaic is a high technology company which develops point-of-need mass spectrometers, designed to improve the efficiency of chemical and biological workflows.
David Evans has personally invested £75,000 as part of the Fundraising. Accordingly, David Evans did not vote as a member of the Board of IIG approving the Investment.
The Investment in Microsaic is the Company's third investment following its successful IPO in mid-December 2020.
For further information, please contact:
Intuitive Investments Group plc |
|
David Evans |
Via Walbrook PR |
|
|
Strand Hanson Limited - Nominated Adviser |
+44 (0) 20 7409 3494 |
James Harris / James Dance / James Bellman |
|
|
|
Turner Pope Investments (TPI) Ltd - Broker |
+44 (0) 20 3657 0050 |
Ben Turner / James Pope / Andrew Thacker |
|
|
|
Walbrook PR Limited - Media & Investor Relations |
+44 (0)20 7933 8780 or intuitive@walbrookpr.com |
Paul McManus |
+44 (0) 7980 541 893 |
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.
About Intuitive Investments Group plc
The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.